503 related articles for article (PubMed ID: 27576327)
1. NLRP3 inflammasome: a promising target in ischemic stroke.
Gao L; Dong Q; Song Z; Shen F; Shi J; Li Y
Inflamm Res; 2017 Jan; 66(1):17-24. PubMed ID: 27576327
[TBL] [Abstract][Full Text] [Related]
2. NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes.
Hong P; Gu RN; Li FX; Xiong XX; Liang WB; You ZJ; Zhang HF
J Neuroinflammation; 2019 Jun; 16(1):121. PubMed ID: 31174550
[TBL] [Abstract][Full Text] [Related]
3. NLRP3 inflammasome contributes to neurovascular unit damage in stroke.
Sun J; Chi L; He Z; Gao Y; Gao Y; Huang Y; Nan G
J Drug Target; 2019 Sep; 27(8):866-875. PubMed ID: 30601069
[TBL] [Abstract][Full Text] [Related]
4. Evidence and perspective for the role of the NLRP3 inflammasome signaling pathway in ischemic stroke and its therapeutic potential (Review).
Ma C; Liu S; Zhang S; Xu T; Yu X; Gao Y; Zhai C; Li C; Lei C; Fan S; Chen Y; Tian H; Wang Q; Cheng F; Wang X
Int J Mol Med; 2018 Dec; 42(6):2979-2990. PubMed ID: 30280193
[TBL] [Abstract][Full Text] [Related]
5. Irisin protects against neuronal injury induced by oxygen-glucose deprivation in part depends on the inhibition of ROS-NLRP3 inflammatory signaling pathway.
Peng J; Deng X; Huang W; Yu JH; Wang JX; Wang JP; Yang SB; Liu X; Wang L; Zhang Y; Zhou XY; Yang H; He YZ; Xu FY
Mol Immunol; 2017 Nov; 91():185-194. PubMed ID: 28961497
[TBL] [Abstract][Full Text] [Related]
6. Evidence that NF-κB and MAPK Signaling Promotes NLRP Inflammasome Activation in Neurons Following Ischemic Stroke.
Fann DY; Lim YA; Cheng YL; Lok KZ; Chunduri P; Baik SH; Drummond GR; Dheen ST; Sobey CG; Jo DG; Chen CL; Arumugam TV
Mol Neurobiol; 2018 Feb; 55(2):1082-1096. PubMed ID: 28092085
[TBL] [Abstract][Full Text] [Related]
7. Arctigenin attenuates ischemic stroke via SIRT1-dependent inhibition of NLRP3 inflammasome.
Zhang S; Jiang L; Che F; Lu Y; Xie Z; Wang H
Biochem Biophys Res Commun; 2017 Nov; 493(1):821-826. PubMed ID: 28888980
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms regulating NLRP3 inflammasome activation.
Jo EK; Kim JK; Shin DM; Sasakawa C
Cell Mol Immunol; 2016 Mar; 13(2):148-59. PubMed ID: 26549800
[TBL] [Abstract][Full Text] [Related]
9. The neuroprotection of Sinomenine against ischemic stroke in mice by suppressing NLRP3 inflammasome via AMPK signaling.
Qiu J; Wang M; Zhang J; Cai Q; Lu D; Li Y; Dong Y; Zhao T; Chen H
Int Immunopharmacol; 2016 Nov; 40():492-500. PubMed ID: 27769021
[TBL] [Abstract][Full Text] [Related]
10. Evidence that NLRC4 inflammasome mediates apoptotic and pyroptotic microglial death following ischemic stroke.
Poh L; Kang SW; Baik SH; Ng GYQ; She DT; Balaganapathy P; Dheen ST; Magnus T; Gelderblom M; Sobey CG; Koo EH; Fann DY; Arumugam TV
Brain Behav Immun; 2019 Jan; 75():34-47. PubMed ID: 30195027
[TBL] [Abstract][Full Text] [Related]
11. Minocycline Suppresses NLRP3 Inflammasome Activation in Experimental Ischemic Stroke.
Lu Y; Xiao G; Luo W
Neuroimmunomodulation; 2016; 23(4):230-238. PubMed ID: 27846628
[TBL] [Abstract][Full Text] [Related]
12. The NLRP3 Inflammasome: An Important Driver of Neuroinflammation in Hemorrhagic Stroke.
Yang SJ; Shao GF; Chen JL; Gong J
Cell Mol Neurobiol; 2018 Apr; 38(3):595-603. PubMed ID: 28752408
[TBL] [Abstract][Full Text] [Related]
13. Electroacupuncture attenuated cerebral ischemic injury and neuroinflammation through α7nAChR-mediated inhibition of NLRP3 inflammasome in stroke rats.
Jiang T; Wu M; Zhang Z; Yan C; Ma Z; He S; Yuan W; Pu K; Wang Q
Mol Med; 2019 May; 25(1):22. PubMed ID: 31117961
[TBL] [Abstract][Full Text] [Related]
14. Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke.
Xu Q; Zhao B; Ye Y; Li Y; Zhang Y; Xiong X; Gu L
J Neuroinflammation; 2021 May; 18(1):123. PubMed ID: 34059091
[TBL] [Abstract][Full Text] [Related]
15. Recent Advances of the NLRP3 Inflammasome in Central Nervous System Disorders.
Zhou K; Shi L; Wang Y; Chen S; Zhang J
J Immunol Res; 2016; 2016():9238290. PubMed ID: 27652274
[TBL] [Abstract][Full Text] [Related]
16. GPCRs in NLRP3 Inflammasome Activation, Regulation, and Therapeutics.
Tang T; Gong T; Jiang W; Zhou R
Trends Pharmacol Sci; 2018 Sep; 39(9):798-811. PubMed ID: 30054020
[TBL] [Abstract][Full Text] [Related]
17. Extracellular ASC exacerbated the recurrent ischemic stroke in an NLRP3-dependent manner.
He XF; Zeng YX; Li G; Feng YK; Wu C; Liang FY; Zhang Y; Lan Y; Xu GQ; Pei Z
J Cereb Blood Flow Metab; 2020 May; 40(5):1048-1060. PubMed ID: 31216943
[TBL] [Abstract][Full Text] [Related]
18. Purinergic 2X7 receptor/NLRP3 pathway triggers neuronal apoptosis after ischemic stroke in the mouse.
Ye X; Shen T; Hu J; Zhang L; Zhang Y; Bao L; Cui C; Jin G; Zan K; Zhang Z; Yang X; Shi H; Zu J; Yu M; Song C; Wang Y; Qi S; Cui G
Exp Neurol; 2017 Jun; 292():46-55. PubMed ID: 28274860
[TBL] [Abstract][Full Text] [Related]
19. Idebenone attenuates cerebral inflammatory injury in ischemia and reperfusion via dampening NLRP3 inflammasome activity.
Peng J; Wang H; Gong Z; Li X; He L; Shen Q; Pan J; Peng Y
Mol Immunol; 2020 Jul; 123():74-87. PubMed ID: 32438202
[TBL] [Abstract][Full Text] [Related]
20. Parkin-Dependent Mitophagy is Required for the Inhibition of ATF4 on NLRP3 Inflammasome Activation in Cerebral Ischemia-Reperfusion Injury in Rats.
He Q; Li Z; Meng C; Wu J; Zhao Y; Zhao J
Cells; 2019 Aug; 8(8):. PubMed ID: 31416289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
